Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Misses Nasdaq Deadline to Retain Stock Listing, Though Continues Trading ...

NEW YORK, March 16 (GenomeWeb News) - Sequenom yesterday missed its Nasdaq-imposed minimum requirement for continued listing after failing to lift its shares above $1 for at least 10 consecutive trading days over the past six months.

 

As GenomeWeb News reported last September, the company had until March 15 to comply with the minimum bid requirement. The shares were trading at $.73 during the mid-afternoon.

 

Calls to Sequenom were not returned. Nasdaq officials deferred to the company.

 

In spite of the threat of imminent delisting, Sequenom shares rallied today on news of a new product launch.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.